Spencer, Holly M <br/><br/>
The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.  [electronic resource] 

 -  The American University law review  Jun 2002 
 - 999-1050 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0003-1453 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Allergic Agents<br/>Cetirizine<br/>Drug Approval<br/>Drug Costs<br/>Drug Labeling<br/>Drug Prescriptions--economics<br/>Gatekeeping--legislation & jurisprudence<br/>Humans<br/>Legislation, Drug<br/>Loratadine<br/>Nonprescription Drugs--economics<br/>Public Health Practice<br/>Terfenadine--analogs & derivatives<br/>United States<br/>United States Food and Drug Administration--legislation & jurisprudence